Thyroid autoimmunity at onset of type 1 diabetes as a predictor of thyroid dysfunction: a thirty-years retrospective longitudinal study
A rational screening strategy for thyroid disease in asymptomatic patients with type 1 diabetes should include measurement of TPO-Abs and thyrotropin at diagnosis, followed by annual thyrotropin assessment in antibody-positive individuals. In patients diagnosed with type 1 diabetes before 18 years of age who are initially antibody-negative, repeat screening every two years from puberty through adulthood is recommended.
Authors
- Antonio Pérez (ORCID: https://orcid.org/0000-0001-5528-1143)
- Cristina Colom (ORCID: https://orcid.org/0000-0002-2926-4697)
- Gemma Carreras (ORCID: https://orcid.org/0000-0002-6718-8381)
- José Luís Sánchez-Quesada (ORCID: https://orcid.org/0000-0003-0224-591X)
- Helena Sardà (ORCID: https://orcid.org/0000-0002-0138-8217)
- Mireia Tirado-Capistros
- Lilian C. Mendoza (ORCID: https://orcid.org/0000-0002-8984-0078)
Institutions
- Universitat Autònoma de Barcelona (ES)
- Instituto de Salud Carlos III (ES)
- Hospital de Sant Pau (ES)
- Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas (ES)
- Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (ES)
- Hospital Clínic de Barcelona (ES)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2025-11-03
- DOI
- https://doi.org/10.3389/fendo.2025.1699111
- Primary Topic
- Thyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00